Valentina Audrito

Turin, 10126, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 51 publications

Correction: Audrito et al. NAMPT Over-Expression Recapitulates the BRAF Inhibitor Resistant Phenotype Plasticity in Melanoma. Cancers 2020, 12, 3855.

Correction: Audrito et al. NAMPT Over-Expression Recapitulates the BRAF Inhibitor Resistant Phenotype Plasticity in Melanoma. Cancers 2020, 12, 3855.

Journal: Cancers

Published: July 06, 2026

Editorial: Tumor-host interactions: metabolic and signaling pathways altered in cancer, immune and stromal cells.

Editorial: Tumor-host interactions: metabolic and signaling pathways altered in cancer, immune and stromal cells.

Journal: Frontiers in molecular biosciences

Published: December 30, 2025

Bi-directional regulation between NAD/NAMPT and IFN-γ/PD-L1 axes via BRD4/IRF1 and mitochondrial respiration in metastatic cutaneous melanoma.

Bi-directional regulation between NAD/NAMPT and IFN-γ/PD-L1 axes via BRD4/IRF1 and mitochondrial respiration in metastatic cutaneous melanoma.

Journal: Journal of experimental & clinical cancer research : CR

Published: December 23, 2025

Secondary amide derivatives of Fe(III)-CDTA: Impact of ligand substitution on relaxivity, stability, and kinetic inertness.

Secondary amide derivatives of Fe(III)-CDTA: Impact of ligand substitution on relaxivity, stability, and kinetic inertness.

Journal: Journal of inorganic biochemistry

Published: December 19, 2025

Special Issue: "Advances in Immunotherapy for Cancer: From Molecular Basis to Novel Biomarkers and Therapeutic Targets".

Special Issue: "Advances in Immunotherapy for Cancer: From Molecular Basis to Novel Biomarkers and Therapeutic Targets".

Journal: International journal of molecular sciences

Published: September 19, 2025

NAMPT and NNMT released via extracellular vesicles and as soluble mediators are distinguished traits of BRAF inhibitor resistance of melanoma cells impacting on the tumor microenvironment.

NAMPT and NNMT released via extracellular vesicles and as soluble mediators are distinguished traits of BRAF inhibitor resistance of melanoma cells impacting on the tumor microenvironment.

Journal: Cell communication and signaling : CCS

Published: April 18, 2025

Editorial: Metabolic reprogramming in cancer.

Editorial: Metabolic reprogramming in cancer.

Journal: Frontiers in pharmacology

Published: February 26, 2025

Impact of holder pasteurization on protein and eNAMPT/Visfatin content in human breast milk.

Impact of holder pasteurization on protein and eNAMPT/Visfatin content in human breast milk.

Journal: Scientific reports

Published: July 31, 2024

TBC1 domain-containing proteins are frequently involved in triple-negative breast cancers in connection with the induction of a glycolytic phenotype.

TBC1 domain-containing proteins are frequently involved in triple-negative breast cancers in connection with the induction of a glycolytic phenotype.

Journal: Cell death & disease

Published: April 10, 2024

The Role of the Toll-like Receptor 2 and the cGAS-STING Pathways in Breast Cancer: Friends or Foes?

The Role of the Toll-like Receptor 2 and the cGAS-STING Pathways in Breast Cancer: Friends or Foes?

Journal: International journal of molecular sciences

Published: November 30, 2023

RICTOR/mTORC2 downregulation in BRAFV600E melanoma cells promotes resistance to BRAF/MEK inhibition.

RICTOR/mTORC2 downregulation in BRAFV600E melanoma cells promotes resistance to BRAF/MEK inhibition.

Journal: Molecular cancer

Published: September 30, 2023

Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma.

Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma.

Journal: Cells

Published: July 01, 2023

Showing 1-12 of 51

Last Updated: 09/26/2026